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Intrapulmonary arteriovenous shunting may be a
universal phenomenon in patients with the
superior cavopulmonary anastomosis:
a radionuclide study
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Abstract
Objective—To evaluate the extent of intrapulmonary right to left shunting in children after bi-
directional cavopulmonary anastomosis (BCPA).
Design—Prospective study of patients who underwent BCPA in a single centre.
Patients—17 patients with complex cyanotic congenital cardiac malformations who underwent
BCPA at 1–45 months of age (median 21 months) were evaluated 15–64 months postoperatively
(median 32 months). Five children between 1 and 10 years (median 5 years) with normal or sur-
gically corrected intracardiac anatomy and peripheral pulmonary circulation who required V/Q
scanning for other reasons were used as controls.
Interventions—All patients underwent cardiac catheterisation to exclude angiographically
demonstrable venovenous collaterals followed by pulmonary perfusion scanning using 99mtechne-
tium (99mTc) labelled albumen microspheres to quantify the intrapulmonary right to left shunt.
Main outcome measure—Percentage of intrapulmonary right to left shunt.
Results—The mean (SD) level of physiological right to left shunting found in the control group
was 5.4 (2.3)%. All patients with BCPA showed the presence of a significantly higher level of
intrapulmonary shunting (26.8 (16.9)%, p < 0.001). The degree of shunting was significantly
increased in the subgroup of 11 patients with BCPA as the only source of pulmonary blood flow
(34.9 (15.8)%), when compared to the six remaining patients with an additional source of pul-
monary blood supply (12.0 (2.6)%, p < 0.001). There was a negative correlation between age at
BCPA and the shunt percentage found in the patients with a competitive source of pulmonary
blood flow (r = −0.63, p < 0.01).
Conclusions—Intrapulmonary right to left shunting develops in all patients following BCPA.
This may be caused by a sustained and inappropriate vasodilatation resulting from absence or
decreased levels of a substance that inhibits pulmonary vasodilatation. Augmenting BCPA with
an additional source of blood flow containing hepatic factor limits the degree of intrapulmonary
arteriovenous shunting and may help provide successful longer term palliation.
(Heart 2000;83:425–428)
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The superior bidirectional cavopulmonary
anastomosis (BCPA) has an established place
in the management of patients with complex
cyanotic congenital heart disease, but progres-
sive systemic desaturation limits the period of
palliation. The aetiology of this is poorly
understood and may be multifactorial. One of
the factors implicated is the development of
macroscopic pulmonary arteriovenous malfor-
mations (PAVM) seen in some of these
patients.1 2 The removal of an “hepatic factor”
in the hepatic venous return from the pulmo-
nary circulation is an appealing hypothesis that
also explains the occurrence of PAVM and
hypoxaemia in patients with liver disease
(hepatopulmonary syndrome).3–5 If the integ-
rity of the pulmonary vasculature is dependent
on hepatic factor then its abrupt elimination
from the pulmonary circulation after BCPA
would lead to early diVusion–perfusion impair-
ment and arteriovenous intrapulmonary shunt-
ing before the development of PAVM. The aim
of our study was to look for evidence of
arteriovenous shunting following BCPA in the
absence of angiographic evidence of PAVM.
Methods
PATIENTS
We studied 17 patients with complex congeni-
tal cardiac malformations who underwent
BCPA but had not yet proceeded to a Fontan
type procedure. The age of the patients at the
time of BCPA was between 1–45 months
(median 21 months) (table 1). The interval
between BCPA and the study was between
15–65 months (median 32 months). All
patients underwent cardiac catheterisation and
angiocardiography. On establishing the ab-
sence of anatomic shunts (venovenous and
venoatrial) they underwent pulmonary per-
fusion scan using 99mtechnetium (99mTc) la-
belled albumin microspheres. Five children
between 1 and 10 years with normal or
surgically corrected intracardiac anatomy and
peripheral pulmonary circulation who required
V/Q scanning for other reasons were used as
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controls (table 1). The protocol of the study
was approved by the South and West England
research ethics committee and informed con-
sent was obtained from the parents of all
patients.
IMAGING TECHNIQUE
All patients were studied using an IGE-400
gamma camera with a low energy general pur-
pose collimator. Images were acquired for
about two minutes in 256 × 256 matrices on to
a Link Medical MAPS 10000 computer. Venti-
lation perfusion scans were acquired for each
patient. A posterior lung ventilation image was
acquired using Kr81m breathed through a mask.
Perfusion images were obtained following
supine injection of 99mTc labelled microspheres
into a right arm vein. We used microaggregates
of the size 8–28 µm so as to enable the
detection of smaller shunts. Approximately
25–35 MBq of 99mTc labelled microspheres
were drawn up into a syringe and measured
accurately in a radioisotope calibrator. After
injection the residual syringe and cannula
activity were measured. Anterior and posterior
lung images were acquired followed by poste-
rior and right lateral abdominal views for
measuring renal depth. The imaging time was
increased if the renal count rate was poor. The
sensitivity of the gamma camera was measured
by using a standard technique. The images
were transferred to a Sun Sparcstation 2 and
were analysed using locally written software
(Portable Image Computer Software).6 The
counts in each image were normalised to take
account of variations in imaging time in
individual patients. The percentage of shunted
blood and the shunt fraction were calculated by
the Chilvers method.7 We made the usual
assumption that the right kidney receives 10%
of the cardiac output so that the percentage
injected dose is: kidney activity × 10 ÷ injected
activity.
The shunt fraction uses the true counts from
the right kidney and the total counts from the
lungs. The lung counts were calculated from
the posterior and anterior views. The region for
each lung was drawn on the posterior ventila-
tion image. The regions were redisplayed on
the perfusion views and the counts were noted.
All counts were corrected for the 99mTc since
the injection and the geometric mean for the
counts for each lung calculated from the two
views. The geometric mean count is then
corrected for attenuation using the thickness of
the lungs.8 9 The shunt fraction was calculated
from the following formula: right kidney
counts × 10 ÷ ((right kidney counts × 10) +
total lung counts).
DATA ANALYSIS
All data are expressed as mean (SD) and range.
The Wilcoxon 2 sample test was used for
statistical analysis of the data and the correla-
tion coeYcient calculated where appropriate.
Values of p < 0.05 were considered significant.
Results
The control group had physiological levels of
intrapulmonary right to left shunting (5.4
(2.3)%) (table 2). All patients with BCPA
showed the presence of intrapulmonary shunt-
ing (20 (15.1)%) significantly higher than the
physiological levels (p < 0.001) (table 1). The
degree of shunting was higher in the subgroup
without competitive pulmonary blood flow
(34.9 (15.8)%), when compared to the sub-
group with a source of pulmonary blood supply
additional to the BCPA (11.8 (2.6)%,
p < 0.001). Although the patients with an
additional source of pulmonary blood flow had
much less shunting, this was still higher than
the level in the control group. A negative corre-
lation was found between the age at BCPA and
the shunt level in the patients with an
additional source of pulmonary blood flow
after BCPA (r = −0.63, p < 0.01).
Discussion
BCPA is increasingly used for interim pallia-
tion of complex cyanotic congenital heart
disease.2 10 Excellent intermediate term pallia-
tion is achieved and the advantages over a sys-
temic to pulmonary arterial shunt are well
established.11–13 However, it is well recognised
that progressive systemic arterial desaturation
occurs and a number of factors have been pro-
posed to explain this.14–16 This includes macro-
scopic PAVM which have long been recognised
as a serious late complication of the cavopul-
monary anastomosis.1 The finding of similar
abnormalities in chronic liver disease lead to
the suggestion that the loss of “hepatic factor”
from the pulmonary circulation might be
responsible for these changes.4 17 If loss or
reduced concentrations of hepatic factor are
implicated in the development of PAVM, then
Table 1 Patients with BCPA undergoing radionuclide scan
Diagnosis
Age at BCPA
(months)
BCPA—study
interval (months)
Shunt
(%)
Competitive
blood supply
DILV, PA 1 60 26 No
DILV, TGA 31 32 19 No
DILV, TGA 2 44 45 No
DILV, TGA 22 33 54 No
DILV, TGA 14 44 64 No
DILV, TGA 40 25 24 No
DIRV, PA 14 65 33 No
TA 26 44 51 No
TA, VSD 2 23 25 No
DILV 35 50 19 No
RI, PA 45 26 24 No
DILV, Band 13 15 10 Yes
PA/IVS, R-BT 37 31 10 Yes
PA/IVS, B-BT 3 64 12 Yes
LI, DORV, PS 2 16 17 Yes
PA/IVS 21 18 11 Yes
DORV, TGA 34 20 11 Yes
B-BT, bilateral Blalock–Taussig shunt; Band, pulmonary artery banding; DILV, double inlet left
ventricle; DORV, double outlet right ventricle; IVS, intact ventricular septum; LI, left isomerism;
PA, pulmonary atresia; PS, pulmonary stenosis; RA, right atrium; R-BT, right Blolock-Taussig
shunt; RI, right isomerism; TA, tricuspid atresia; TGA, transposition of the great arteries; VSD,
ventricular septal defect.
Table 2 Control group of patients undergoing radionuclide
scan
Age
(years) Diagnosis
Shunt
(%)
1 Arterial correction for TGA, LPA stenosis 3
4 Arterial correction for TGA, LPA stenosis 7
5 Arterial correction for TGA, LPA stenosis 3
5 Full correction for PA/VSD 8
10 Frequent chest infection 6
LPA, left pulmonary artery; PA, pulmonary atresia; TGA,
transposition of great arteries; VSD, ventricular septal defect
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pulmonary arteriovenous shunting (a right to
left shunt) should occur early following BCPA,
and PAVM merely represent the end stage of
the process.
Various methods are now available for the
demonstration of intrapulmonary shunting.
Contrast echocardiography, though employed
frequently,18 has limited use as it cannot quan-
tify the shunt or assess its progression. Lung
perfusion scanning using 99mTc labelled micro-
aggregated albumin microspheres has been
found to be highly specific in the detection of
clinically significant intrapulmonary
shunting.7 19 20 Our study confirms that lung
perfusion scanning using 99mTc labelled micro-
aggregated albumin microspheres of only
8–28 µm is a useful method for detecting and
quantifying intrapulmonary shunting even at
physiological levels in normal subjects.
We have shown the presence of increased
intrapulmonary shunting in all patients studied
(range 10–64%) compared to the controls
(3–8%). Patients with BCPA as the only source
of pulmonary blood flow had a significantly
higher volume of intrapulmonary shunting
compared to those with competitive pulmo-
nary blood flow (p < 0.001). The degree of
intrapulmonary shunting correlated well with
patients’ clinical status as those with more than
25% shunt have subsequently gone on to have
the modified Fontan procedure completed
because of progressive cyanosis. Interestingly,
competitive pulmonary blood flow limited the
degree of intrapulmonary shunting to low lev-
els (range 10–17%), but were still mildly and
significantly raised compared to the controls
(3–8%). The lack of complete protection in this
group may be explained by the uneven
distribution of various sources of pulmonary
blood supply. The BCPA provides up to 88%
of blood flow to the ipsilateral lung and this
may dilute the protective eVect of hepatic
factor from the competitive source.21 The
occurrence of PAVM predominantly in the
right lung following the Glenn procedure sup-
ports this hypothesis.1 Unfortunately, the tech-
nique we have employed cannot identify the
degree of intrapulmonary shunting occurring
in each lung, confirming only an overall reduc-
tion in pulmonary arteriovenous shunting in
the presence of competitive pulmonary blood
flow. This finding diVers from previous studies
using contrast echocardiography which have
suggested that pulsatile pulmonary blood flow
(competitive flow) does not have a significant
eVect on the development of intrapulmonary
shunting.22 We believe that this reflects the dif-
ference in the methodologies used to study the
shunting, as contrast echocardiography cannot
determine the degree of shunting but only its
presence or absence.
The negative correlation observed between
the age at BCPA and intrapulmonary shunting
seen in our small subgroup of patients with
competitive blood flow is not inconsistent with
the finding of others and may be related to the
persistent primordial arteriovenous connec-
tions present in children less than 6 months of
age.22 Our observation that competitive pulmo-
nary blood flow restricted the degree of
intrapulmonary shunting, irrespective of the
duration of follow up, lends support to this type
of approach to the surgical management of
complex congenital heart defects. Moreover,
we also have some evidence that later introduc-
tion of competitive blood flow to BCPA may
reduce intrapulmonary right to left shunting.23
One of our patients with significant intrapul-
monary shunting and desaturation after BCPA
(saturation 65%, shunt 45%) improved dra-
matically one week after her pulmonary blood
flow was augmented by a contralateral modi-
fied Blalock–Taussig shunt (saturation 80%,
shunt 25%). Similar improvement of systemic
arterial saturations have been observed in
patients with hepatopulmonary syndrome after
liver transplantation.24–28
These observations support the hypothesis
that normal pulmonary vascular tone is main-
tained by a fine balance between stimulatory
and inhibitory influences.29 We believe that the
factor(s) with inhibitory eVect on vasodilata-
tion should at least in part be supplied by the
liver. This hepatic factor must be largely or
completely removed by the systemic circulation
in its first pass, resulting in its insignificant
concentration in the superior caval blood.
Unopposed precapillary and capillary vasodila-
tation would follow in the lung or the parts
perfused by the blood without hepatic factor.30
Interestingly, patients who have normal hepa-
tocellular function but have portal vein occlu-
sion from diVerent causes also develop
PAVM.31 32 Even the “unusual” cases of PAVM
reported in the literature in association with
carcinoid syndrome had associated portal vein
obstruction.33 34 From these observations it is
possible to infer that hepatic factor is under the
influence of a “portal venous factor” that regu-
lates its synthesis. We therefore propose that
portal venous factor present in the portal
venous blood is normally modified or elimi-
nated by the liver. When portal venous factor
either partly or fully bypasses the hepatic
microcirculation, as in portal vein obstruction
or portal hypertension, it would enter unmodi-
fied into the pulmonary and systemic circula-
tion leading to systemic and pulmonary
vasodilatation. Thus, the liver seems to play a
crucial role in the metabolism of both hepatic
factor and portal venous factor. While travers-
ing the hepatic parenchyma, portal venous fac-
tor stimulates production or is modified into
hepatic factor which inhibits vasodilatation.
Imbalance in the relative concentrations of
portal venous factor and hepatic factor may
result in intrapulmonary shunting, PAVM, or
even pulmonary hypertension.
This study helps us to understand further
the pathophysiology of arteriovenous shunting
following BCPA and the eVect of competitive
flow. It suggests that shunting is inevitable in
the absence of competitive flow, but is
significantly attenuated in its presence. Further
studies are required to determine the rate of
progression of arteriovenous shunting and the
longer term role of competitive flow in their
prevention. At this time the amount of
competitive flow necessary to prevent the
development of clinically important arteriov-
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enous shunting and the biochemical mecha-
nisms involved remain unknown.
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